Detalhe da pesquisa
1.
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.
Cell
; 163(1): 202-17, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26388441
2.
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826.
Cancer Sci
; 113(11): 3877-3887, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792064
3.
Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma.
Int J Gynecol Cancer
; 29(2): 277-281, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636710
4.
An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023.
BMC Cancer
; 18(1): 771, 2018 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064406
5.
Targeting of Aberrant αvß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.
Mol Ther
; 25(1): 259-273, 2017 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129120
6.
Measurement of endometrial thickness in premenopausal women in office gynecology.
Reprod Med Biol
; 17(1): 29-35, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371818
7.
Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.
Br J Cancer
; 117(5): 717-724, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28728166
8.
Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy.
Int J Gynecol Cancer
; 27(8): 1666-1674, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28786875
9.
Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
Int J Gynecol Cancer
; 27(7): 1325-1332, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28557832
10.
Apparent diffusion coefficient (ADC) measurement in ovarian tumor: Effect of region-of-interest methods on ADC values and diagnostic ability.
J Magn Reson Imaging
; 43(3): 720-5, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26201495
11.
Fertility-sparing surgery for uterine cervical cancer.
Future Oncol
; 12(20): 2345-55, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27578750
12.
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Int J Clin Oncol
; 21(3): 580-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26614089
13.
Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
Int J Clin Oncol
; 21(5): 969-974, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142771
14.
Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Gynecol Oncol
; 137(1): 34-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25662625
15.
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.
Int J Gynecol Cancer
; 25(4): 570-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25756405
16.
Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.
Int J Clin Oncol
; 20(5): 967-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25744580
17.
Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.
Int J Clin Oncol
; 20(3): 556-60, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24993674
18.
Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.
Support Care Cancer
; 22(11): 2891-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24825735
19.
Dual inhibition of phosphatidylinositol 3'-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach for mucinous adenocarcinoma of the ovary.
Int J Gynecol Cancer
; 24(3): 444-53, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552895
20.
Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.
Int J Gynecol Cancer
; 24(1): 61-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362713